Related Experiment Video

Updated: Apr 27, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

2.4K

Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway

Jie Zheng1, Wei Du, Lai-Jun Song

  • 1Department of Neurosurgery, Xinxiang Central Hospital, 56 Jinsui Avenue, Xinxiang, Henan, China. zhengjie256@126.com.

World Journal of Surgical Oncology
|July 16, 2014
PubMed
Abstract

Insights

Norcantharidin effectively inhibits glioma cell growth and induces apoptosis. This compound shows promise as a novel therapeutic option for malignant glioma patients.

Area of Science:

  • Oncology
  • Neuro-oncology
  • Pharmacology

Background:

  • Malignant gliomas are the most common primary brain tumors with a poor prognosis.
  • Current therapies offer limited efficacy, necessitating novel treatment strategies.
  • Norcantharidin demonstrates in vitro efficacy in inhibiting glioma cell growth.

Purpose of the Study:

  • To investigate the anti-cancer effects of norcantharidin on glioma cell lines.
  • To elucidate the underlying molecular mechanisms of norcantharidin's action.

Main Methods:

  • Glioma cell lines (U87, C6) were treated with norcantharidin.
  • Cell proliferation was assessed using MTT assay.
  • Apoptosis and signaling pathway changes (MEK, ERK, Bcl-2 family) were analyzed via flow cytometry and Western blotting.

Main Results:

  • Norcantharidin significantly inhibited glioma cell proliferation and induced apoptosis.
  • Treatment reduced the expression of phospho-MEK and phospho-ERK.
  • Expression of anti-apoptotic proteins Bcl-2 and Mcl-1 decreased, while Bcl-xL and Bax remained unchanged.

Conclusions:

  • Norcantharidin exhibits potent anti-glioma activity in vitro.
  • The drug functions by inhibiting the MEK/ERK pathway and modulating apoptosis-related proteins.
  • Norcantharidin represents a potential new therapeutic agent for glioma treatment.

More Related Videos

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.1K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K